Gene · 10399
Papers3,110
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,110
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic and Proteomic Analyses of Myzus persicae Carrying Brassica Yellows Virus. | Biology (Basel) | 2023 | 37508340 | PubTator, text mining | PubMed |
| RNA binding protein: coordinated expression between the nuclear and mitochondrial genomes in tumors. | J Transl Med | 2023 | 37507746 | PubTator, text mining | PubMed |
| Identification of Proteomic Biomarkers in Proliferative Verrucous Leukoplakia through Liquid Chromatography With Tandem Mass Spectrometry. | Lab Invest | 2023 | 37507024 | PubTator, text mining | PubMed |
| Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil. | Clin Transl Med | 2023 | 37491740 | PubTator, text mining | PubMed |
| The respiratory syncytial virus M2-2 protein is targeted for proteasome degradation and inhibits translation and stress granules assembly. | PLoS One | 2023 | 37490507 | PubTator, text mining | PubMed |
| Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis. | Front Oncol | 2023 | 37483521 | PubTator, text mining | PubMed |
| A defined roadmap of radial glia and astrocyte differentiation from human pluripotent stem cells. | Stem Cell Reports | 2023 | 37451260 | PubTator, text mining | PubMed |
| Pharmacological Activity of Cepharanthine. | Molecules | 2023 | 37446681 | PubTator, text mining | PubMed |
| TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells. | Cell Death Dis | 2023 | 37443145 | PubTator, text mining | PubMed |
| RAB11A and RAB11B control mitotic spindle function in intestinal epithelial progenitor cells. | EMBO Rep | 2023 | 37424454 | PubTator, text mining | PubMed |
| Inhibition of neutral sphingomyelinase 2 impairs HIV-1 envelope formation and substantially delays or eliminates viral rebound. | Proc Natl Acad Sci U S A | 2023 | 37406092 | PubTator, text mining | PubMed |
| Differential expression of the circadian clock network correlates with tumour progression in gliomas. | BMC Med Genomics | 2023 | 37400829 | PubTator, text mining | PubMed |
| Bioinformatics analysis and identification of hub genes of neutrophils in Kawasaki disease: a pivotal study. | Clin Rheumatol | 2023 | 37394620 | PubTator, text mining | PubMed |
| Characterization of RACK1-depleted mammalian cells by a palette of microscopy approaches reveals defects in cell cycle progression and polarity establishment. | Exp Cell Res | 2023 | 37393981 | PubTator, text mining | PubMed |
| Secretory carrier-associated membrane protein 5 regulates cell-surface targeting of T-type calcium channels. | Channels (Austin) | 2023 | 37389974 | PubTator, text mining | PubMed |
| Dimethyl Fumarate and Intestine: From Main Suspect to Potential Ally against Gut Disorders. | Int J Mol Sci | 2023 | 37373057 | PubTator, text mining | PubMed |
| Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity. | Int J Mol Sci | 2023 | 37372966 | PubTator, text mining | PubMed |
| Serine/Threonine Protein Phosphatases 1 and 2A in Lung Endothelial Barrier Regulation. | Biomedicines | 2023 | 37371733 | PubTator, text mining | PubMed |
| USP10 Contributes to Colon Carcinogenesis via mTOR/S6K Mediated HIF-1α but Not HIF-2α Protein Synthesis. | Cells | 2023 | 37371055 | PubTator, text mining | PubMed |
| Non-POU Domain-Containing Octomer-Binding (NONO) protein expression and stability promotes the tumorigenicity and activation of Akt/MAPK/β-catenin pathways in human breast cancer cells. | Cell Commun Signal | 2023 | 37370134 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10399/papers?page=14